This issue is available in PDF format to paid subscribers (certain restrictions apply).
If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 59   1998   NUMBER 3

Brainstorms

101 Nitric Oxide Physiology and Pharmacology. Stephen M. Stahl
[PDF]

Original Articles

103 Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder. Francesco Benedetti, Laura Sforzini, Cristina Colombo, Cesare Maffei, and Enrico Smeraldi
[Abstract] [PDF]

108 Borderline Personality Symptomatology, Experience of Multiple Types of Trauma, and Health Care Utilization Among Women in a Primary Care Setting. Randy A. Sansone, Michael W. Wiederman, and Lori A. Sansone
[Abstract] [PDF]

112 Bupropion as an Antidote for Serotonin Reuptake Inhibitor_Induced Sexual Dysfunction. Adam Keller Ashton and Raymond C. Rosen
[Abstract] [PDF]

116 A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression. Richard L. Rudolph, Louis F. Fabre, John P. Feighner, Karl Rickels, Richard Entsuah, and Albert T. Derivan
[Abstract] [PDF]

123 A Meta-Analysis of Eight Randomized, Double-Blind, Controlled Clinical Trials of Mirtazapine for the Treatment of Patients With Major Depression and Symptoms of Anxiety. Jan Fawcett and Robert L. Barkin
[Abstract] [PDF]

128 Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia. Peter N. van Harten, Jan C. A. M. van Trier, Ernst H. Horwitz, Glenn E. Matroos, and Hans W. Hoek
[Abstract] [PDF]

CME Activity 136

137 Differences in Self-Reported Sleep Complaints in Elderly Persons Living in the Community Who Do or Do Not Take Sleep Medication. Sabine Englert and Michael Linden
[Abstract] [PDF]

Letters to the Editor

131 Rebound Psychiatric and Physical Symptoms After Gabapentin Discontinuation. Gabriela Corá-Locatelli, Benjamin D. Greenberg, Juliet D. Martin, and Dennis L. Murphy
[PDF]

131 Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation. Hsien-Yuan Lane, Kuan-Pin Su, Wen-Ho Chang, and Michael W. Jann
[PDF]

133 Can Bruxism Respond to Serotonin Reuptake Inhibitors? Dan J. Stein, Gustav Van Greunen, and Dana Niehaus
[PDF]

133 Article Commended. Edward C. Lauterbach, Jonathan M. Meyer, and George M. Simpson
[PDF]

134 Possible Dose-Response Relationship for Risperidone in Obsessive-Compulsive Disorder. Robert W. Baker
[PDF]

Reply by Dan J. Stein, Susan Hawkridge, Colin Bouwer, and Robin A. Emsley [PDF]

Book Reviews 135

Information for authors

see January 1998, pages 33_34